Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11873349 Compositions and methods related to IL27 receptor binding

Patent 11873349 was granted and assigned to Synthekine on January, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Synthekine

Current Assignee

Synthekine

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

118733490

Patent Inventor Names

Deepti Rokkam0

Patrick Lupardus0

Robert Kastelein0

Date of Patent

January 16, 2024

Patent Application Number

181643860

Date Filed

February 3, 2023

Patent Citations

‌

US Patent 10421807 Interleukin-31 monoclonal antibody

‌

US Patent 8258268 Dual variable domain immunoglobulin and uses thereof

‌

US Patent 8921528 Bispecific fusion antibodies with enhanced serum half-life

‌

US Patent 8975382 Amino acid sequences directed against HER2 and polypeptides comprising the same for the treatment of cancers and/or tumors

‌

US Patent 9334331 Bispecific antibodies

‌

US Patent 10927186 T cell recruiting polypeptides based on TCR alpha/beta reactivity

Patent Primary Examiner

CPC Code

Patent abstract

Provided herein are IL27R binding proteins that bind to IL27Rα and gp130 and comprise an anti-IL27Rα V

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11873349 Compositions and methods related to IL27 receptor binding

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API

By using this site, you agree to our Terms of Service.